CONCLUSIONS

Lung cancer is the leading cause of death due to cancer in the United States. While the majority of the patients have advanced disease at the time of presentation, complete surgical resection remains the best hope for cure for non-small cell lung carcinoma. After determining that lung cancer is present, a number of complementary approaches are used to determine the histological type of cancer, the degree of invasion, and the patient’s cardiac and pulmonary reserve. Patients with limited disease and adequate physiologic reserve should undergo lung cancer resection.

Corresponding author: Andrew Chang, Department of Surgery, University of Michigan Medical Center, 2120 Taubman Center, 1500 E. Medical Center Drive, Box 0344, Ann Arbor, Michigan 48109, Phone: (734) 763-7418, Fax: (734) 615-2656, E-mail: .(JavaScript must be enabled to view this email address)

Authored by: Jules Lin, M.D.₍₁₎, Richard K.J. Brown, M.D. ₍₂₎, and Andrew C. Chang, M.D. ₍₃₎
Author Information

₁ General Surgery Resident, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109
₂ Clinical Associate Professor, Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
₃ Assistant Professor, Department of Surgery, Section of Thoracic Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109

Corresponding author: Andrew Chang, Department of Surgery, University of Michigan Medical Center, 2120 Taubman Center, 1500 E. Medical Center Drive, Box 0344, Ann Arbor, Michigan 48109, Phone: (734) 763-7418, Fax: (734) 615-2656, E-mail: .(JavaScript must be enabled to view this email address) Cancer: Selecting Patients for Surgical Resection

1. Landreneau, R. J., Mack, M. J., Dowling, R. D., Luketich, J. D., Keenan, R. J., Ferson, P. F., and Hazelrigg, S. R. The role of thoracoscopy in lung cancer management. Chest, 113: 6S-12S, 1998.
2. Leo, F. and Pastorino, U. Surgery in small-cell lung carcinoma. Where is the rationale? Semin Surg Oncol, 21: 176-181, 2003.
3. Leonard, C. T., Whyte, R. I., and Lillington, G. A. Primary non-small-cell lung cancer: determining the suitability of the patient and tumor for resection. Curr Opin Pulm Med, 6: 391-395, 2000.
4. Martini, N., Bains, M. S., Burt, M. E., Zakowski, M. F., McCormack, P., Rusch, V. W., and Ginsberg, R. J. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg, 109: 120-129, 1995.
5. Reed, C. E., Harpole, D. H., Posther, K. E., Woolson, S. L., Downey, R. J., Meyers, B. F., Heelan, R. T., MacApinlac, H. A., Jung, S. H., Silvestri, G. A., Siegel, B. A., and Rusch, V. W. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg, 126: 1943-1951, 2003.
6. Passlick, B. Initial surgical staging of lung cancer. Lung Cancer, 42 Suppl 1: S21-25, 2003.
7. Mac Manus, M. P. and Hicks, R. J. PET scanning in lung cancer: current status and future directions. Semin Surg Oncol, 21: 149-155, 2003.
8. Romano, P. S. and Mark, D. H. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest, 101: 1332-1337, 1992.
9. Olsen, G. N., Bolton, J. W., Weiman, D. S., and Hornung, C. A. Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years’ experience. Chest, 99: 587-590, 1991.
10. Liptay, M. J. and Fry, W. A. Complications from induction regimens for thoracic malignancies. Perioperative considerations. Chest Surg Clin N Am, 9: 79-95, 1999.
11. Warner, M. A., Divertie, M. B., and Tinker, J. H. Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients. Anesthesiology, 60: 380-383, 1984.
12. Marom, E. M, Sarah, S., James E. H., and Patz, E.F. Jr
T1 Lung Cancers: Sensitivity of Diagnosis with Fluorodeoxyglucose PET
Radiology 2002; 223: 453-459.
13. Gambhir, S.S., Czernin, J., Schwimmer, J., Silverman D.H.S., Coleman, E.R., and Phelps, M.E., A Tabulated Summary of the FDG PET Literature. Journal of Nuclear Medicine Vol. 42 No. 90050 1S-93S